Loading insider details...
Beta
Latest Form 4 (Jul 17, 2026): Gift of 29,555 STOK shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 17, 2026 | Stoke Therapeutics, Inc. (STOK) | Gift | 29,555 | n/a |
| Jun 5, 2026 | Stoke Therapeutics, Inc. (STOK) | Grant/Award | 17,786 | n/a |
| Dec 9, 2025 | Akero Therapeutics, Inc. (AKRO) | Disposition to Issuer | 136,301 | n/a |
| Jun 5, 2025 | Akero Therapeutics, Inc. (AKRO) | Grant/Award | 9,398 | n/a |
| Jun 5, 2025 | Stoke Therapeutics, Inc. (STOK) | Grant/Award | 29,747 | n/a |
| Jun 11, 2024 | Akero Therapeutics, Inc. (AKRO) | Grant/Award | 26,000 | n/a |
| Jun 7, 2024 | Stoke Therapeutics, Inc. (STOK) | Grant/Award | 7,639 | n/a |
| Jun 27, 2023 | Akero Therapeutics, Inc. (AKRO) | Grant/Award | 15,000 | n/a |
| Jun 15, 2023 | Stoke Therapeutics, Inc. (STOK) | Grant/Award | 19,441 | n/a |
| Dec 2, 2022 | Akero Therapeutics, Inc. (AKRO) | Sale | 6,322 | $293.6K |